CLINICAL_TRIALS
trial_result
· 2019-12-26
Clinical Trial Update: An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients [Phase 2]
Summary
Open-label extension study of BPS-MR-PAH-201 in pulmonary arterial hypertension completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lung Biotechnology PBC | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-12-26